Savara Announces Pricing of 100.0 Million Underwritten Offering of Common Stock
| SVRA Stock | USD 3.36 0.20 5.62% |
About 62% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
LANGHORNE, Pa., June 28, 2024--Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of 26,246,720 shares of its common stock at a price of 3.81 per share before deducting underwriting discounts and commissions, for total gross proceeds of approximately 100.0 million. All of the securities to be sold in the offering are being sold by Savara. The offering included the following investo
Read at finance.yahoo.com
 |
Savara Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Savara can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Savara Fundamental Analysis
We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
Savara is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Savara Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.
Peers
Savara Related Equities
| PTIX | Protagenic Therapeutics | 5.77 | ||||
| KZR | Kezar Life | 2.21 | ||||
| IKNA | Ikena Oncology | 1.80 | ||||
| FENC | Fennec Pharmaceuticals | 1.32 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.97 | ||||
| ANAB | AnaptysBio | 0.92 | ||||
| RVMD | Revolution Medicines | 0.53 | ||||
| GPCR | Structure Therapeutics | 0.06 | ||||
| XOMAO | XOMA | 0.39 | ||||
| ACLX | Arcellx | 0.82 | ||||
| XLO | Xilio Development | 0.93 | ||||
| DYN | Dyne Therapeutics | 1.19 | ||||
| RZLT | Rezolute | 1.39 | ||||
| SRRK | Scholar Rock | 2.11 | ||||
| TPST | Tempest Therapeutics | 2.20 | ||||
| AVTE | Aerovate Therapeutics | 2.23 | ||||
| EWTX | Edgewise Therapeutics | 2.58 | ||||
| XOMA | XOMA Corp | 2.71 | ||||
| STOK | Stoke Therapeutics | 3.63 | ||||
| TRDA | Entrada Therapeutics | 4.69 | ||||
| TARA | Protara Therapeutics | 6.30 | ||||
| ALXO | Alx Oncology | 8.14 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |